Literature DB >> 24799989

Mechanisms of fibrogenesis in liver cirrhosis: The molecular aspects of epithelial-mesenchymal transition.

Sun-Jae Lee1, Kyung-Hyun Kim1, Kwan-Kyu Park1.   

Abstract

Liver injuries are repaired by fibrosis and regeneration. The cause of fibrosis and diminished regeneration, especially in liver cirrhosis, is still unknown. Epithelial-mesenchymal transition (EMT) has been found to be associated with liver fibrosis. The possibility that EMT could contribute to hepatic fibrogenesis reinforced the concept that activated hepatic stellate cells are not the only key players in the hepatic fibrogenic process and that other cell types, either hepatic or bone marrow-derived cells could contribute to this process. Following an initial enthusiasm for the discovery of this novel pathway in fibrogenesis, more recent research has started to cast serious doubts upon the real relevance of this phenomenon in human fibrogenetic disorders. The debate on the authenticity of EMT or on its contribution to the fibrogenic process has become very animated. The overall result is a general confusion on the meaning and on the definition of several key aspects. The aim of this article is to describe how EMT participates to hepatic fibrosis and discuss the evidence of supporting this possibility in order to reach reasonable and useful conclusions.

Entities:  

Keywords:  Biological markers; Epithelial-mesenchymal transition; Fibrosis; Liver; Transforming growth factor-beta1

Year:  2014        PMID: 24799989      PMCID: PMC4009476          DOI: 10.4254/wjh.v6.i4.207

Source DB:  PubMed          Journal:  World J Hepatol


  101 in total

Review 1.  Portal tract fibrogenesis in the liver.

Authors:  Giuliano Ramadori; Bernhard Saile
Journal:  Lab Invest       Date:  2004-02       Impact factor: 5.662

Review 2.  TGF-beta and epithelial-to-mesenchymal transitions.

Authors:  Jiri Zavadil; Erwin P Böttinger
Journal:  Oncogene       Date:  2005-08-29       Impact factor: 9.867

Review 3.  Cytokines and cellular crosstalk involved in the activation of fat-storing cells.

Authors:  A M Gressner
Journal:  J Hepatol       Date:  1995       Impact factor: 25.083

4.  The bone marrow functionally contributes to liver fibrosis.

Authors:  Francesco P Russo; Malcolm R Alison; Brian W Bigger; Eunice Amofah; Aikaterini Florou; Farhana Amin; George Bou-Gharios; Rosemary Jeffery; John P Iredale; Stuart J Forbes
Journal:  Gastroenterology       Date:  2006-05       Impact factor: 22.682

5.  Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis.

Authors:  J P Iredale; R C Benyon; M J Arthur; W F Ferris; R Alcolado; P J Winwood; N Clark; G Murphy
Journal:  Hepatology       Date:  1996-07       Impact factor: 17.425

6.  Rat liver myofibroblasts and hepatic stellate cells differ in CD95-mediated apoptosis and response to TNF-alpha.

Authors:  Bernhard Saile; Nina Matthes; Katrin Neubauer; Christoph Eisenbach; Hammoudeh El-Armouche; Joszef Dudas; Giuliano Ramadori
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-08       Impact factor: 4.052

7.  Extracellular matrix modulates sensitivity of hepatocytes to fibroblastoid dedifferentiation and transforming growth factor beta-induced apoptosis.

Authors:  Patricio Godoy; Jan G Hengstler; Iryna Ilkavets; Christoph Meyer; Anastasia Bachmann; Alexandra Müller; Gregor Tuschl; Stefan O Mueller; Steven Dooley
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425

8.  The epithelial mesenchymal transition confers resistance to the apoptotic effects of transforming growth factor Beta in fetal rat hepatocytes.

Authors:  Francisco Valdés; Alberto M Alvarez; Annamaria Locascio; Sonia Vega; Blanca Herrera; Margarita Fernández; Manuel Benito; M Angela Nieto; Isabel Fabregat
Journal:  Mol Cancer Res       Date:  2002-11       Impact factor: 5.852

9.  Mesenchymal stem cells facilitate recovery from chemically induced liver damage and decrease liver fibrosis.

Authors:  Yao-Jen Chang; Jen-Wea Liu; Po-Cheng Lin; Li-Yi Sun; Chih-Wen Peng; Geng-Hong Luo; Tse-Min Chen; Ru-Ping Lee; Shinn-Zong Lin; Horng-Jyh Harn; Tzyy-Wen Chiou
Journal:  Life Sci       Date:  2009-08-15       Impact factor: 5.037

10.  Epithelial-mesenchymal transition in cells expanded in vitro from lineage-traced adult human pancreatic beta cells.

Authors:  Holger A Russ; Philippe Ravassard; Julie Kerr-Conte; Francois Pattou; Shimon Efrat
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

View more
  21 in total

1.  Reduced Glutathione Level Promotes Epithelial-Mesenchymal Transition in Lens Epithelial Cells via a Wnt/β-Catenin-Mediated Pathway: Relevance for Cataract Therapy.

Authors:  Zongbo Wei; Jane Caty; Jeremy Whitson; Amy D Zhang; Ramkumar Srinivasagan; Terrance J Kavanagh; Hong Yan; Xingjun Fan
Journal:  Am J Pathol       Date:  2017-08-19       Impact factor: 4.307

2.  The let-7/Lin28 axis regulates activation of hepatic stellate cells in alcoholic liver injury.

Authors:  Kelly McDaniel; Li Huang; Keisaku Sato; Nan Wu; Tami Annable; Tianhao Zhou; Sugeily Ramos-Lorenzo; Ying Wan; Qiaobing Huang; Heather Francis; Shannon Glaser; Hidekazu Tsukamoto; Gianfranco Alpini; Fanyin Meng
Journal:  J Biol Chem       Date:  2017-05-23       Impact factor: 5.157

3.  Suberoylanilide Hydroxamic Acid (SAHA) Reduces Fibrosis Markers and Deactivates Human Stellate Cells via the Epithelial-Mesenchymal Transition (EMT).

Authors:  Merve Özel; Mevlut Baskol; Hilal Akalın; Gulden Baskol
Journal:  Cell Biochem Biophys       Date:  2021-03-10       Impact factor: 2.194

4.  Prolyl oligopeptidase attenuates hepatic stellate cell activation through induction of Smad7 and PPAR-γ.

Authors:  Da Zhou; Jing Wang; Ling-Nan He; Bing-Hang Li; Yong-Nian Ding; Yuan-Wen Chen; Jian-Gao Fan
Journal:  Exp Ther Med       Date:  2017-01-05       Impact factor: 2.447

5.  Epithelial-mesenchymal transition in liver fibrosis.

Authors:  Ya-Lei Zhao; Rong-Tao Zhu; Yu-Ling Sun
Journal:  Biomed Rep       Date:  2016-01-25

Review 6.  A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition.

Authors:  Wenting Xu; Zhen Yang; Nonghua Lu
Journal:  Cell Adh Migr       Date:  2015-08-04       Impact factor: 3.405

Review 7.  Neovascularization is a key feature of liver fibrosis progression: anti-angiogenesis as an innovative way of liver fibrosis treatment.

Authors:  Mariia Zadorozhna; Sante Di Gioia; Massimo Conese; Domenica Mangieri
Journal:  Mol Biol Rep       Date:  2020-02-10       Impact factor: 2.316

8.  Downregulation of TGF-β Receptor-2 Expression and Signaling through Inhibition of Na/K-ATPase.

Authors:  Jennifer La; Eleanor Reed; Lan Chan; Larisa V Smolyaninova; Olga A Akomova; Gökhan M Mutlu; Sergei N Orlov; Nickolai O Dulin
Journal:  PLoS One       Date:  2016-12-22       Impact factor: 3.240

9.  MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2.

Authors:  De-Ning Ma; Zong-Tao Chai; Xiao-Dong Zhu; Ning Zhang; Di-Hua Zhan; Bo-Gen Ye; Cheng-Hao Wang; Cheng-Dong Qin; Yi-Ming Zhao; Wei-Ping Zhu; Man-Qing Cao; Dong-Mei Gao; Hui-Chuan Sun; Zhao-You Tang
Journal:  J Hematol Oncol       Date:  2016-01-06       Impact factor: 17.388

Review 10.  Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the "Reactive" Biliary Epithelial Phenotype.

Authors:  Luca Fabris; Simone Brivio; Massimiliano Cadamuro; Mario Strazzabosco
Journal:  Stem Cells Int       Date:  2016-01-06       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.